Literature DB >> 16780466

What is standard of care in the evaluation of elastosis perforans serpiginosa? A survey of pediatric dermatologists.

David Vearrier1, Robert L Buka, Brandie Roberts, Bari B Cunningham, Lawrence F Eichenfield, Sheila F Friedlander.   

Abstract

Elastosis perforans serpiginosa is a rare chronic dermatosis characterized by extrusion of altered elastic fibers through the epidermis. It often occurs in association with a variety of connective tissue disorders, and may develop following penicillamine therapy; however, it may also present without comorbidities. There are currently no well-established protocols for the investigation of possible associated disorders in patients who present with elastosis perforans serpiginosa. We describe three patients with idiopathic elastosis perforans serpiginosa seen at our clinic and review the standard of care among 31 pediatric dermatologists surveyed who have cared for such a patient within the last 2 years. Based upon the results of our survey, we conclude that most pediatric dermatologists limit their evaluation of such patients to a thorough patient history and physical examination. This limited approach may be a sufficient evaluation in affected patients who are otherwise healthy.

Entities:  

Mesh:

Year:  2006        PMID: 16780466     DOI: 10.1111/j.1525-1470.2006.00221.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  2 in total

1.  Elastosis Perforans Serpiginosa in a patient with Down syndrome treated with imiquimod 5% cream.

Authors:  Pernille Axél Gregersen; Birgitte Stausbøl-Grøn; Mette Ramsing; Mette Sommerlund
Journal:  Dermatol Reports       Date:  2010-10-29

2.  Elastosis perforans serpiginosa: a review of the literature and our own experience.

Authors:  Adriana Polańska; Monika Bowszyc-Dmochowska; Ryszard W Żaba; Zygmunt Adamski; Adam Reich; Aleksandra Dańczak-Pazdrowska
Journal:  Postepy Dermatol Alergol       Date:  2016-10-21       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.